european medicines agency news

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday. This marks the regulator's second backing for a use of Wegovy beyond weight loss and further strengthens Novo's case that the medicine has multiple health benefits.

YAHOO!Finance · 5h

European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide 2.4 mg) label. The label update incorporates data showing that Wegovy,

The Wall Street Journal on MSN · 10h

Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure in obese patients.

Business Insider · 14h

Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a

Medscape1h

Two New Drugs Approved for Age-Related Macular Degeneration

The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...

DPA International on MSN3h

EU extends authorization of the mpox vaccine to adolescents

The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

Merck Gets European Panel Backing for Keytruda in Two Gynecologic Cancers

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

Medscape18m

Hympavzi Approved in Europe for Severe Hemophilia A and B

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

anglocelt.ie28m

'After all our life helping in the health system... We need help now'

The community in west Cavan is rallying around a popular retired local GP in a bid to help pay for specialist cancer therapy ...

Pharmabiz8h

EMA’s human medicines committee elects Bruno Sepodes as new chair

EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...

Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...

The New York Times3d

European Medicines Agency

The European Medicines Agency also said that extra doses of the Moderna and Pfizer-BioNTech vaccines could be given to people with underlying health conditions as early as 28 days after a second ...

AbbVie Gets CHMP Backing for Elahere in Ovarian Cancer

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

Apellis Receives Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU Following Re-Examination

This CHMP opinion was made despite broad support for pegcetacoplan from the European retina community and multiple dissenting votes by CHMP members who supported a path to approval.” “We have seen the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics